Scandinavian ChemoTech AB (publ) (STO:CMOTEC.B)
Sweden · Delayed Price · Currency is SEK 3.890
-0.010 (-0.26%)
Apr 24, 2026, 4:38 PM CET
Scandinavian ChemoTech AB Market Cap
Scandinavian ChemoTech AB has a market cap or net worth of 99.02 million as of April 24, 2026. Its market cap has increased by 210.74% in one year.
Market Cap
99.02M
Enterprise Value
95.35M
Revenue
12.29M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.89
Market Cap Chart
Since December 6, 2016, Scandinavian ChemoTech AB's market cap has increased from 63.83M to 99.02M, an increase of 55.13%. That is a compound annual growth rate of 4.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2026 | 99.27M | -15.29% |
| Dec 30, 2025 | 117.19M | 180.45% |
| Dec 30, 2024 | 41.79M | -4.97% |
| Dec 29, 2023 | 43.97M | -27.52% |
| Dec 30, 2022 | 60.67M | -63.03% |
| Dec 30, 2021 | 164.08M | 100.32% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 6, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NextCell Pharma AB | 135.45M |
| IRLAB Therapeutics AB | 129.11M |
| Nanologica AB | 127.77M |
| Simris Group AB (PUBL) | 117.97M |
| Annexin Pharmaceuticals AB | 106.59M |
| Biovica International AB | 99.25M |
| Magle Chemoswed Holding AB | 94.16M |
| Alzinova AB | 87.40M |